No photo of Matthew J. Akiyama

View Scopus Profile

Matthew J. Akiyama, M.D.

  • 99 Citations
  • 7 h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Matthew J. Akiyama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Hepacivirus Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Risk-Taking Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
HIV Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2019

Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial

Akiyama, M. J.

National Institutes of Health

8/15/17 → 7/31/19

Project: Research project

Hepatitis C
Hepacivirus
Criminal Law
Mentors
Risk-Taking

Publications 2008 2019

  • 99 Citations
  • 7 h-Index
  • 17 Article
  • 2 Review article
  • 1 Comment/debate
  • 1 Letter
2 Citations (Scopus)

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs

Jost, J., Tempalski, B., Vera, T., Akiyama, M. J., Mangalonzo, A. P. & Litwin, A. H., Jun 2 2019, In : International journal of environmental research and public health. 16, 11

Research output: Contribution to journal › Article

Open Access
Risk-Taking
Hepacivirus
Pharmaceutical Preparations
Interviews
Syringes
4 Citations (Scopus)

Intensive models of hepatitis C care for people who inject drugs receiving opioid agonist therapy a randomized controlled trial

Akiyama, M. J., Norton, B. L., Arnsten, J. H., Agyemang, L., Heo, M. & Litwin, A. H., Jan 1 2019, In : Annals of internal medicine. 170, 9, p. 594-603 10 p.

Research output: Contribution to journal › Article

Hepatitis C
Opioid Analgesics
Randomized Controlled Trials
Pharmaceutical Preparations
Directly Observed Therapy

Letter to the Editor: Hepatitis C Virus Prevalence Estimates Among Incarcerated Persons

Spaulding, A. C., Graham, C. S., Akiyama, M. J., Chhatwal, J., Nijhawan, A. E., Ninburg, M. H., Rich, J. D., Strick, L. B., Taylor, L. E., Trooskin, S. B., Westergaard, R. P. & Sabol, W. J., Jan 1 2019, In : Hepatology. 70, 2, p. 758-759 2 p.

Research output: Contribution to journal › Letter

Hepacivirus

Linkage to hepatitis C care after incarceration in jail: A prospective, single arm clinical trial

Akiyama, M. J., Columbus, D., MacDonald, R., Jordan, A. O., Schwartz, J., Litwin, A. H., Eckhardt, B. & Carmody, E., Aug 8 2019, In : BMC Infectious Diseases. 19, 1, 703.

Research output: Contribution to journal › Article

Open Access
Hepatitis C
Hepacivirus
Clinical Trials
Patient Navigation
Community Health Services
1 Citation (Scopus)

Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study

Akiyama, M. J., Cleland, C. M., Lizcano, J. A., Cherutich, P. & Kurth, A. E., Nov 2019, In : The Lancet Infectious Diseases. 19, 11, p. 1255-1263 9 p.

Research output: Contribution to journal › Article

Harm Reduction
Kenya
Risk-Taking
Hepacivirus
Cohort Studies